MedTrace Logo

Coordinated Access for Addiction Recovery and Equity in VA Supportive Housing

NCT07141394 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 7908

Last updated 2025-10-10

No results posted yet for this study

Summary

The Department of Housing and Urban Development-VA Supportive Housing (HUD-VASH) Program provides subsidized permanent housing with case management to homeless-experienced Veterans (HEVs). Up to 40% of Veterans exit HUD-VASH within two years of attaining housing; substance use disorders (SUDs) are one of the largest causes of returns to homelessness for HEVs. CARE-VASH QUERI proposes to implement and evaluate two evidence-based SUD services - Medications for addiction treatment (MAT) and cognitive behavioral therapy for SUDs (CBT-SUD) - among Veterans in HUD-VASH.

Conditions

  • Homelessness
  • Substance Use Disorder (SUD)

Interventions

DRUG

Medication for Addiction Treatment (MAT)

MAT includes medications for alcohol use disorder (MAUD) and medications for opioid use disorder (MAUD). It reduces substance use, increases SUD treatment engagement, enhances quality of life, and reduces overdoses.

BEHAVIORAL

Cognitive Behavioral Therapy for Substance Use Disorders (CBT-SUD)

An evidence-based psychotherapy that uses cognitive behavioral therapy to further recovery goals across SUD diagnoses.

Sponsors & Collaborators

Principal Investigators

  • Sonya Emi Gabrielian, MD MPH · VA Greater Los Angeles Healthcare System, West Los Angeles, CA

  • Evelyn T Chang, MD MSHS · VA Greater Los Angeles Healthcare System, Sepulveda, CA

  • Erin P Finley, PhD MPH · VA Greater Los Angeles Healthcare System, West Los Angeles, CA

  • Emily Treichler, PhD · VA San Diego Healthcare System, San Diego, CA

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-10-01
Primary Completion
2030-09-30
Completion
2030-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07141394 on ClinicalTrials.gov